Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
1.180
-0.070 (-5.60%)
At close: Dec 5, 2025, 4:00 PM EST
1.240
+0.060 (5.08%)
After-hours: Dec 5, 2025, 6:55 PM EST
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $21.80 million as of December 5, 2025. Its market cap has decreased by -46.18% in one year.
Market Cap
21.80M
Enterprise Value
17.59M
1-Year Change
-46.18%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $21.80M, a decrease of -29.00%. That is a compound annual growth rate of -3.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 21.30M | -31.07% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.67B |
| Johnson & Johnson | 487.88B |
| AbbVie | 403.79B |
| UnitedHealth Group | 301.54B |
| AstraZeneca | 279.81B |
| Novartis AG | 257.47B |
| Merck & Co. | 251.78B |
| Abbott Laboratories | 216.99B |